Since CD44 is overexpressed in a variety of tumor cells, HA-coated self-assembling nanoparticles or liposomes have been tested for the delivery of siRNAs and/or chemotherapy drugs in pre-clinical xenograft models. Here, CD44 is linked to neoplasm.